22 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
, in connection with the sale of Series A convertible preferred stock, we entered into a royalty transfer agreement with MPM Oncology Charitable Foundation, Inc
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
with MPM Oncology Charitable Foundation, Inc. and UBS Optimus Foundation, or the Royalty Transfer Agreement. We have agreed to pay a royalty of 1 … transfer agreement with MPM Oncology Charitable Foundation, Inc., or MPM Charitable Foundation, and UBS Optimus Foundation, or the Royalty Transfer
DRS
4w4i3b0wbf5jjbs
28 Jan 21
Draft registration statement
12:00am
424B4
reqoshh 1gt6a1ugxgym
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
EX-10.19
9qx59
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.18
3jyd7tdxjsfozcj4
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.16
iwgyj8neebo 6o71k
11 Sep 20
IPO registration
4:49pm
S-1
4fr0r anu2glo6i
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.12
3ypu6
11 Sep 20
IPO registration
4:49pm
DRS/A
7y98dk
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
nvew6l igk21
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
mxeeg7c1bdbbo5do
20 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.19
e90t79i3
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
EX-10.18
d0th 08wmv56
31 Oct 19
Draft registration statement
12:00am
DRS
EX-10.16
31t8khdbdg vsqqoir
31 Oct 19
Draft registration statement
12:00am